+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

ACP Journal Club. Review: In older persons at vascular risk, statins do not prevent dementia or cognitive decline at 3.5 to 5 years



ACP Journal Club. Review: In older persons at vascular risk, statins do not prevent dementia or cognitive decline at 3.5 to 5 years



Annals of Internal Medicine 164(8): Jc42-Jc42




(PDF emailed within 0-6 h: $19.90)

Accession: 057108268

Download citation: RISBibTeXText

PMID: 27089091

DOI: 10.7326/ACPJC-2016-164-8-042


Related references

ACP Journal Club. Review: statins are not associated with cognitive impairment, Alzheimer disease, or dementia. Annals of Internal Medicine 160(10): Jc10-Jc11, 2014

ACP Journal Club. Review: statins are not associated with cognitive impairment or dementia in cognitively intact adults. Annals of Internal Medicine 160(10): Jc11, Jc10-Jc11, Jc10, 2014

ACP Journal Club. Review: Cholinesterase inhibitors do not prevent dementia in patients with mild cognitive impairment. Annals of Internal Medicine 160(8): Jc11-Jc11, 2014

ACP Journal Club. Review: cholinesterase inhibitors but not memantine increase syncope in older adults with mild cognitive impairment or dementia. Annals of Internal Medicine 155(10): Jc5-J10, 2012

ACP Journal Club. Review: Long-term annual conversion rate to dementia was 3.3% in older adults with mild cognitive impairment. Annals of Internal Medicine 150(8): Jc4-J13, 2009

ACP Journal Club. Review: Calcium supplementation and risk for fracture in persons > 50 years of age. Annals of Internal Medicine 164(2): Jc4-Jc4, 2016

ACP Journal Club. Review: high-dose oral vitamin D supplements and active vitamin D prevent falls in older persons. Annals of Internal Medicine 152(2): Jc1-Jc3, 2010

ACP Journal Club. Review: Statins do not increase adverse cognitive effects in patients with or without initial cognitive impairment. Annals of Internal Medicine 162(10): Jc6-Jc6, 2015

Treatment of cardiovascular risk factors to prevent cognitive decline and dementia: a systematic review. Vascular Health and Risk Management 6(): 775-785, 2010

ACP Journal Club. Review: in older patients without CVD, statins reduce MI and stroke but not all-cause mortality. Annals of Internal Medicine 160(10): Jc8-Jc8, 2014

Vascular risk factors, cognition and dementia incidence over 6 years in the Sydney older persons study. Neuroepidemiology 22(3): 165-171, May-June, 2003

ACP Journal Club. Review: Statins do not increase risk for intracerebral hemorrhage. Annals of Internal Medicine 156(6): Jc3-Jc6, 2012

The influence of vascular risk factors on cognitive decline in patients with dementia: a systematic review. Maturitas 76(2): 113-117, 2014

Relation of neuropathology with cognitive decline among older persons without dementia. Frontiers in Aging Neuroscience 5(): 50-50, 2013

ACP Journal Club. Review: Statins reduce mortality and major vascular events in patients with no history of CV disease. Annals of Internal Medicine 159(2): Jc2-Jc2, 2013